Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10428350 Methods and compositions for the activation of gamma-delta T-cells

Patent 10428350 was granted and assigned to American Gene Technologies on October, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

American Gene Technologies

0

Current Assignee

American Gene Technologies

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Charles David Pauza0

Tyler Lahusen0

Haishan Li0

Mei-Ling Liou0

Date of Patent

October 1, 2019

0

Patent Application Number

161824430

Date Filed

November 6, 2018

0

Patent Citations

US Patent 10036040 Methods and compositions for the activation of gamma-delta T-cells

US Patent 10233464 HIV pre-immunization and immunotherapy

US Patent 10023880 Methods and compositions for the activation of gamma-delta T-cells

US Patent 10036038 HIV pre-immunization and immunotherapy

US Patent 10137144 Methods and compositions for the activation of gamma-delta T-cells

Patent Citations Received

US Patent 11519006 Methods and compositions for the activation of gamma-delta T-cells

US Patent 11534450 Methods and compositions for the activation of gamma-delta T-cells

Patent Primary Examiner

0

Patent abstract

The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta T-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10428350 Methods and compositions for the activation of gamma-delta T-cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool